Cargando…

Oral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology

Tofacitinib, an oral Janus kinase inhibitor (Jakinib), is an emerging treatment modality whose well-established efficacy in systemic inflammatory diseases is now being actively explored for cutaneous disorders (arising due to the patient's dysimmune responses) that are not responding to and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonthalia, Sidharth, Aggarwal, Parul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743407/
https://www.ncbi.nlm.nih.gov/pubmed/31544068
http://dx.doi.org/10.4103/idoj.IDOJ_474_18